Orexigen Therapeutics (FRA:JXS1) Research & Development : €25.54 Mil (TTM As of Sep. 2017)

View and export this data going back to . Start your Free Trial

What is Orexigen Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Orexigen Therapeutics's Research & Development for the three months ended in Sep. 2017 was €4.85 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2017 was €25.54 Mil.

Orexigen Therapeutics Research & Development Historical Data

The historical data trend for Orexigen Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexigen Therapeutics Research & Development Chart

Orexigen Therapeutics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Research & Development

Get a 7-Day Free Trial

56.14

41.43

46.56

37.41

36.05

Orexigen Therapeutics Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Apr18
Research & Development	Get a 7-Day Free Trial															6.37	7.64	6.68	4.85	-

Orexigen Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was €25.54 Mil.

Orexigen Therapeutics (FRA:JXS1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Orexigen Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Orexigen Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexigen Therapeutics (FRA:JXS1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexigen Therapeutics Inc (FRA:JXS1) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

3344 North Torrey Pines Court, Suite 200, La Jolla, CA, USA, 92037

Website

http://www.orexigen.com

Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity.

Orexigen Therapeutics (FRA:JXS1) Headlines

No Headlines